Jiewei Xu
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- RNA Research and Splicing
- RNA and protein synthesis mechanisms
- Ubiquitin and proteasome pathways
- Circular RNAs in diseases
Papers in
-
- RNA Research and Splicing 6
- RNA modifications and cancer 6
- Ubiquitin and proteasome pathways 6
- Genomics and Chromatin Dynamics 4
- Bioinformatics and Genomic Networks 3
- Protein Degradation and Inhibitors 2
-
- Cancer-related molecular mechanisms research 5
- Co-authors
- Yongcan Xu (5 shared papers)Nevan J. Krogan (18 shared papers)Zhong Wang (2 shared papers)Assen Roguev (8 shared papers)Jun Lu (2 shared papers)Hao Jiang (1 shared paper)Michael Shales (5 shared papers)Hao Jiang (3 shared papers)
- Journals
- Cold Spring Harbor Protocols (4 papers)Therapeutics and Clinical Risk Management (2 papers)Molecular Genetics and Genomics (1 paper)Nature Communications (1 paper)Clinical Breast Cancer (1 paper)
- Partner nations
- United StatesChinaIreland
In The Last Decade
Jiewei Xu
34 papers receiving 481 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 130
- Molecular Biology 371
- Virology 19
- Genetics 54
- Oncology 49
Countries citing papers authored by Jiewei Xu
This map shows the geographic impact of Jiewei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiewei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiewei Xu more than expected).
Fields of papers citing papers by Jiewei Xu
This network shows the impact of papers produced by Jiewei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiewei Xu. The network helps show where Jiewei Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiewei Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 46 | |
| 2 | 2018 | 45 | |
| 3 | 2019 | 44 | |
| 4 | 2021 | 39 | |
| 5 | 2019 | 35 | |
| 6 | 2015 | 23 | |
| 7 | 2017 | 22 | |
| 8 | 2022 | 21 | |
| 9 | 2024 | 18 | |
| 10 | 2019 | 17 | |
| 11 | 2018 | 16 | |
| 12 | 2013 | 15 | |
| 13 | 2018 | 14 | |
| 14 | 2014 | 13 | |
| 15 | 2020 | 13 | |
| 16 | 2021 | 12 | |
| 17 | 2022 | 12 | |
| 18 | 2014 | 11 | |
| 19 | 2018 | 11 | |
| 20 | 1997 | 10 |
About Jiewei Xu
Jiewei Xu is a scholar working on Molecular Biology, Cancer Research, Cell Biology, Genetics and Spectroscopy, having authored 34 papers that have together received 486 indexed citations. Recurring topics across this work include RNA Research and Splicing (6 papers), RNA modifications and cancer (6 papers), Ubiquitin and proteasome pathways (6 papers), Cancer-related molecular mechanisms research (5 papers), Genomics and Chromatin Dynamics (4 papers), Advanced Proteomics Techniques and Applications (3 papers), Bioinformatics and Genomic Networks (3 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Cancer Research (130 citations), Molecular Biology (371 citations), Virology (19 citations), Genetics (54 citations) and Oncology (49 citations). Jiewei Xu has collaborated with scholars based in United States, China and Ireland. Frequent co-authors include Yongcan Xu, Nevan J. Krogan, Zhong Wang, Assen Roguev, Jun Lu, Hao Jiang, Michael Shales, Hao Jiang, Ruth Hüttenhain and Weiguo Lü. Their work appears in journals such as Cold Spring Harbor Protocols, Therapeutics and Clinical Risk Management, Molecular Genetics and Genomics, Nature Communications and Clinical Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.